Donor and recipient chemokine receptor CCR5 genotype is associated with survival after bone marrow transplantation.
about
Identification and utilization of donor and recipient genetic variants to predict survival after HCT: are we ready for primetime?Genetic variants of human granzyme B predict transplant outcomes after HLA matched unrelated bone marrow transplantation for myeloid malignancies.Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease.The effect of the CCR5-delta32 deletion on global gene expression considering immune response and inflammationC-C chemokine receptor type five (CCR5): An emerging target for the control of HIV infection.The CCR5-delta32 polymorphism as a model to study host adaptation against infectious diseases and to develop new treatment strategies.Genomic studies of GVHD-lessons learned thus far.Role of non-HLA gene polymorphisms in graft-versus-host disease.Reduced intensity conditioning for allogeneic hematopoietic cell transplantation: considerations for evidence-based GVHD prophylaxis.Replication and validation of genetic polymorphisms associated with survival after allogeneic blood or marrow transplant.The Frequency of CCR5del32 Mutation in Populations of Russians, Tatars and Bashkirs of Chelyabinsk Region, Russia.Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxis.Incidence and dynamics of active cytomegalovirus infection in allogeneic stem cell transplant patients according to single nucleotide polymorphisms in donor and recipient CCR5, MCP-1, IL-10, and TLR9 genes.The effect of CCR5Δ32 on the risk of grade 3-4 acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis.Pharmacodynamic Monitoring Predicts Outcomes of CCR5 Blockade as Graft-versus-Host Disease Prophylaxis.
P2860
Q28080914-E493252D-AE81-493C-86F6-61A41AF7D031Q34008970-795D1160-8FA0-4D96-9524-5833C7D73166Q34640239-B98D3B1D-CBC5-4D35-8C12-37B5D6040D13Q35602698-5F2F2CA7-7162-4E02-AE4C-F56A5502F4F1Q37463869-E7F33DAD-CE39-46C5-A31E-115ED80E1DB1Q37895793-E2529953-18A0-407E-B5C7-05A2908B2D85Q37985519-ECE9CECD-A3EE-4937-A1B4-8EF3DAA34514Q38129337-59436576-AFC3-4849-9C37-635AE877EDE5Q38202155-310935F9-FA4A-46C8-8638-92661D072336Q38623211-8E2A0114-A22B-4E9F-B30D-501AFD3845C9Q39023070-0D0C5FBB-09F4-44E1-B627-75707A7E96DFQ39037369-DFCFD3E6-6B9B-4F8F-AD67-1E4CD64E1457Q42199375-D1CE39B2-557C-4825-A774-8AEDB0FD2AEFQ45871437-4442AF75-5157-474C-8C29-35E5D9FA0E3AQ48622749-C8D2BC13-AF87-4007-81D9-2F2B90D9C96B
P2860
Donor and recipient chemokine receptor CCR5 genotype is associated with survival after bone marrow transplantation.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Donor and recipient chemokine ...... r bone marrow transplantation.
@ast
Donor and recipient chemokine ...... r bone marrow transplantation.
@en
type
label
Donor and recipient chemokine ...... r bone marrow transplantation.
@ast
Donor and recipient chemokine ...... r bone marrow transplantation.
@en
prefLabel
Donor and recipient chemokine ...... r bone marrow transplantation.
@ast
Donor and recipient chemokine ...... r bone marrow transplantation.
@en
P2093
P2860
P1433
P1476
Donor and recipient chemokine ...... r bone marrow transplantation.
@en
P2093
Edgar Milford
Huong Thi Bich Tran
Manza A Agovi
Stacy M Ricklefs
Stephen F Porcella
Stephen Spellman
Susan E Conway
P2860
P304
P356
10.1182/BLOOD-2009-08-237768
P407
P577
2010-01-12T00:00:00Z